PL2825528T3 - Podstawione pirolidyno-2-karboksyamidy - Google Patents

Podstawione pirolidyno-2-karboksyamidy

Info

Publication number
PL2825528T3
PL2825528T3 PL13708466T PL13708466T PL2825528T3 PL 2825528 T3 PL2825528 T3 PL 2825528T3 PL 13708466 T PL13708466 T PL 13708466T PL 13708466 T PL13708466 T PL 13708466T PL 2825528 T3 PL2825528 T3 PL 2825528T3
Authority
PL
Poland
Prior art keywords
carboxamides
substituted pyrrolidine
pyrrolidine
substituted
Prior art date
Application number
PL13708466T
Other languages
English (en)
Inventor
Daniel Fishlock
David Joseph Bartkovitz
Xin-Jie Chu
Binh Thanh Vu
Chunlin Zhao
Original Assignee
F.Hoffmann-La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F.Hoffmann-La Roche Ag filed Critical F.Hoffmann-La Roche Ag
Publication of PL2825528T3 publication Critical patent/PL2825528T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Polyethers (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL13708466T 2012-03-15 2013-03-12 Podstawione pirolidyno-2-karboksyamidy PL2825528T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261611200P 2012-03-15 2012-03-15

Publications (1)

Publication Number Publication Date
PL2825528T3 true PL2825528T3 (pl) 2017-09-29

Family

ID=47844360

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13708466T PL2825528T3 (pl) 2012-03-15 2013-03-12 Podstawione pirolidyno-2-karboksyamidy

Country Status (27)

Country Link
US (1) US8993614B2 (pl)
EP (1) EP2825528B1 (pl)
JP (1) JP6125546B2 (pl)
KR (1) KR20140138165A (pl)
CN (1) CN104271554B (pl)
AR (1) AR090328A1 (pl)
AU (1) AU2013203662B2 (pl)
BR (1) BR112014018959A8 (pl)
CA (1) CA2860781A1 (pl)
CL (1) CL2014001858A1 (pl)
CO (1) CO6990736A2 (pl)
CR (1) CR20140399A (pl)
DK (1) DK2825528T3 (pl)
EA (1) EA025557B1 (pl)
ES (1) ES2634290T3 (pl)
HU (1) HUE032864T2 (pl)
IL (1) IL234173A (pl)
MX (1) MX2014010942A (pl)
NZ (1) NZ626505A (pl)
PE (1) PE20142185A1 (pl)
PH (1) PH12014501542B1 (pl)
PL (1) PL2825528T3 (pl)
SG (1) SG11201404344XA (pl)
SI (1) SI2825528T1 (pl)
TW (1) TWI586648B (pl)
UA (1) UA113541C2 (pl)
WO (1) WO2013135648A1 (pl)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201406889WA (en) 2012-05-30 2015-02-27 Hoffmann La Roche Substituted pyrrolidine-2-carboxamides
EP2935263B1 (en) 2012-12-20 2018-12-05 Merck Sharp & Dohme Corp. Substituted imidazopyridines as hdm2 inhibitors
KR20160011668A (ko) * 2013-06-24 2016-02-01 에프. 호프만-라 로슈 아게 안정한 정맥내 투여 제형
HK1215453A1 (zh) * 2013-07-03 2016-08-26 豪夫迈.罗氏有限公司 用於将用mdm2拮抗剂进行患者癌症治疗个人化的基於mrna的基因表达
AR097584A1 (es) 2013-09-12 2016-03-23 Hoffmann La Roche Terapia de combinación de anticuerpos contra el csf-1r humano y anticuerpos contra el pd-l1 humano
RS60142B1 (sr) * 2013-12-05 2020-05-29 Hoffmann La Roche Novi kombinovani tretman za akutnu mijeloidnu leukemiju (aml)
US9657351B2 (en) 2013-12-06 2017-05-23 Hoffman-La Roche Inc. MRNA-based gene expression for personalizing patient cancer therapy with an MDM2 antagonist
US10227298B2 (en) * 2014-04-15 2019-03-12 Hoffmann-La Roche Inc. Solid forms of a pharmaceutically active compound
WO2015176135A1 (en) * 2014-05-22 2015-11-26 The University Of Sydney Omega-3 analogues
CN106716131B (zh) * 2014-10-10 2020-07-24 豪夫迈·罗氏有限公司 Mdm2拮抗剂的癌症疗法的患者个性化方法
CN104496822B (zh) * 2014-12-15 2016-10-26 扬州三友合成化工有限公司 一种1-氯乙基环己基丙基碳酸酯的制备方法
AU2016256911B2 (en) 2015-05-07 2022-03-31 Agenus Inc. Anti-OX40 antibodies and methods of use thereof
SG10201912984WA (en) 2015-12-02 2020-03-30 Agenus Inc Antibodies and methods of use thereof
CN118436801A (zh) 2016-05-20 2024-08-06 豪夫迈·罗氏有限公司 Protac抗体缀合物及其使用方法
CN107698598B (zh) * 2016-08-08 2019-06-21 肖飞 螺环吲哚酮聚乙二醇碳酸酯类化合物和其组合物、制备方法及用途
EP3498712B1 (en) * 2016-08-08 2024-01-03 Jiangsu Yayo Biotechnology Co. Ltd Spirocyclic indolone polyethylene glycol carbonate compound, composition, preparation method and use thereof
JP7138094B2 (ja) 2016-08-25 2022-09-15 エフ・ホフマン-ラ・ロシュ・アクチェンゲゼルシャフト マクロファージ活性化剤と組み合わせた抗csf-1r抗体の間欠投与
MA46770A (fr) 2016-11-09 2019-09-18 Agenus Inc Anticorps anti-ox40, anticorps anti-gitr, et leurs procédés d'utilisation
JP7304287B2 (ja) 2016-12-22 2023-07-06 エフ・ホフマン-ラ・ロシュ・アクチェンゲゼルシャフト 抗pd-l1/pd1治療の不成功後の、抗pd-l1抗体との組み合わせでの抗csf-1r抗体を用いた腫瘍の治療
CA3086522A1 (en) * 2017-12-20 2019-06-27 Angex Pharmaceutical, Inc. Carbamate and urea compounds as multikinase inhibitors
CN114230561B (zh) * 2020-09-09 2024-03-19 中国人民解放军海军军医大学 一种mdm2抑制剂类小分子化合物及用途
WO2023056069A1 (en) 2021-09-30 2023-04-06 Angiex, Inc. Degrader-antibody conjugates and methods of using same
WO2024240858A1 (en) 2023-05-23 2024-11-28 Valerio Therapeutics Protac molecules directed against dna damage repair system and uses thereof

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0720857B2 (ja) 1988-08-11 1995-03-08 テルモ株式会社 リポソームおよびその製法
DE69120141T2 (de) 1990-03-28 1996-11-28 Shuji Kojima Polymerkombiniertes Arzneimittel zur Magenbehandlung und Verfahren zu dessen Herstellung
US5681811A (en) 1993-05-10 1997-10-28 Protein Delivery, Inc. Conjugation-stabilized therapeutic agent compositions, delivery and diagnostic formulations comprising same, and method of making and using the same
GB9317618D0 (en) 1993-08-24 1993-10-06 Royal Free Hosp School Med Polymer modifications
KR100361933B1 (ko) 1993-09-08 2003-02-14 라 졸라 파마슈티칼 컴파니 화학적으로정의된비중합성결합가플랫폼분자및그것의콘주게이트
AU1313695A (en) 1993-12-14 1995-07-03 Sandoz Ltd. Pharmaceutical compositions containing alkyl polyoxyalkylene carboxylates
DE4435087A1 (de) 1994-09-30 1996-04-04 Deutsches Krebsforsch Konjugat zur Behandlung von Infektions-, Autoimmun- und Hauterkrankungen
JP2001508783A (ja) 1997-01-29 2001-07-03 ポリマスク・ファーマシューティカルズ・パブリック・リミテッド・カンパニー Peg化法
AU9402198A (en) 1997-09-26 1999-04-23 Becton Dickinson & Company Preparing conjugates using polyethylene glycol linkers
US6165509A (en) 1998-09-01 2000-12-26 University Of Washington Pegylated drug complexed with bioadhesive polymer suitable for drug delivery and methods relating thereto
US6294192B1 (en) 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US6713454B1 (en) 1999-09-13 2004-03-30 Nobex Corporation Prodrugs of etoposide and etoposide analogs
CA2414076A1 (en) 2000-06-08 2001-12-13 La Jolla Pharmaceutical Company Multivalent platform molecules comprising high molecular weight polyethylene oxide
EP1405871A4 (en) 2001-05-30 2004-11-17 Mitsubishi Kagaku Iatron Inc METHOD FOR BINDING A SUBSTANCE TO BE INCORPORATED AT A POLYMER END
US6939874B2 (en) * 2001-08-22 2005-09-06 Amgen Inc. Substituted pyrimidinyl derivatives and methods of use
US7144978B2 (en) 2002-01-15 2006-12-05 Pan Asia Bio Co., Ltd. Multidrop tree branching functional polyethylene glycol, methods of preparing and using same
DK3025726T3 (da) 2002-01-18 2019-12-09 Biogen Ma Inc Polyalkylenpolymerforbindelser og anvendelser deraf
US7482376B2 (en) 2003-07-03 2009-01-27 3-Dimensional Pharmaceuticals, Inc. Conjugated complement cascade inhibitors
JP4954864B2 (ja) 2004-04-01 2012-06-20 カーディオム ファーマ コーポレイション イオンチャネル調節化合物のプロドラッグおよびその使用
TW200616604A (en) 2004-08-26 2006-06-01 Nicholas Piramal India Ltd Nitric oxide releasing prodrugs containing bio-cleavable linker
JP4920593B2 (ja) 2004-10-25 2012-04-18 インテザイン テクノロジーズ, インコーポレイテッド ヘテロ二官能性ポリ(エチレングリコール)およびそれらの使用
NZ561215A (en) 2005-02-22 2010-12-24 Univ Michigan Small molecule inhibitors of MDM2 and uses thereof
WO2007127473A2 (en) 2006-04-27 2007-11-08 Intezyne Technologies, Inc. Poly (ethylene glycol) containing chemically disparate endgroups
WO2008109783A2 (en) 2007-03-06 2008-09-12 The Regents Of The University Of California Detecting spin perturbations using magnetic resonance imaging
CN101357986B (zh) 2007-06-13 2013-06-05 康达医药科技有限公司 聚乙二醇功能性衍生物和制造方法
WO2009128789A1 (en) 2008-04-17 2009-10-22 Agency For Science, Technology And Research Vesicles for intracellular drug delivery
WO2009155431A1 (en) 2008-06-18 2009-12-23 University Of Louisville Research Foundation, Inc. Methods for targeted cancer treatment and detection
KR101311597B1 (ko) 2008-07-14 2013-09-26 바이오콘 리미티드 올리고머의 실질적으로 단분산된 혼합물의 합성 방법
MX2011001887A (es) 2008-08-22 2011-04-04 Baxter Int Derivados de bencil carbonato polimericos.
CA2734363C (en) 2008-09-18 2016-10-25 F. Hoffmann-La Roche Ag Substituted pyrrolidine-2-carboxamides
US8354444B2 (en) 2008-09-18 2013-01-15 Hoffmann-La Roche Inc. Substituted pyrrolidine-2-carboxamides
US8709467B2 (en) 2009-06-26 2014-04-29 Cute Lovable Teddy Bear, Llc. Para-xylylene based microfilm elution devices
US20110118283A1 (en) 2009-11-17 2011-05-19 Qingjie Ding Substituted Pyrrolidine-2-Carboxamides
US20120065210A1 (en) 2010-09-15 2012-03-15 Xin-Jie Chu Substituted hexahydropyrrolo[1,2-c]imidazolones
CN101991860B (zh) 2010-11-08 2013-06-19 中国药科大学 泊洛沙姆-羧酸类药物偶联物及其制备方法与应用
CA2817585A1 (en) 2010-11-12 2012-05-18 The Regents Of The University Of Michigan Spiro-oxindole mdm2 antagonists
CA2825926A1 (en) 2011-02-02 2012-08-09 Ontario Institute For Cancer Research Cellulose-based nanoparticles for drug delivery
WO2012116073A2 (en) 2011-02-23 2012-08-30 The Board Of Trustees Of The University Of Illinois Amphiphilic dendron-coils, micelles thereof and uses
CN102247602B (zh) 2011-06-13 2013-01-02 中山大学 一种超分子水凝胶双重药物载体及其制备方法和应用
US20130052130A1 (en) 2011-08-30 2013-02-28 University Of Washington Branched Discreet PEG Constructs
SG11201406889WA (en) * 2012-05-30 2015-02-27 Hoffmann La Roche Substituted pyrrolidine-2-carboxamides

Also Published As

Publication number Publication date
CR20140399A (es) 2014-10-07
AU2013203662A1 (en) 2013-10-03
CN104271554A (zh) 2015-01-07
US20130244958A1 (en) 2013-09-19
AR090328A1 (es) 2014-11-05
SI2825528T1 (sl) 2017-08-31
ES2634290T3 (es) 2017-09-27
EA025557B1 (ru) 2017-01-30
CA2860781A1 (en) 2013-09-19
TWI586648B (zh) 2017-06-11
BR112014018959A2 (pl) 2017-06-20
PH12014501542A1 (en) 2014-09-22
CO6990736A2 (es) 2014-07-10
KR20140138165A (ko) 2014-12-03
JP2015512890A (ja) 2015-04-30
EP2825528B1 (en) 2017-05-24
DK2825528T3 (en) 2017-08-14
PH12014501542B1 (en) 2014-09-22
CN104271554B (zh) 2016-11-23
SG11201404344XA (en) 2014-10-30
UA113541C2 (xx) 2017-02-10
HK1200830A1 (en) 2015-08-14
IL234173A (en) 2017-08-31
WO2013135648A1 (en) 2013-09-19
HUE032864T2 (en) 2017-11-28
EP2825528A1 (en) 2015-01-21
AU2013203662B2 (en) 2016-04-14
US8993614B2 (en) 2015-03-31
BR112014018959A8 (pt) 2017-07-11
TW201341357A (zh) 2013-10-16
EA201491623A1 (ru) 2014-12-30
NZ626505A (en) 2016-04-29
MX2014010942A (es) 2014-11-14
JP6125546B2 (ja) 2017-05-10
CL2014001858A1 (es) 2014-09-26
PE20142185A1 (es) 2014-12-29

Similar Documents

Publication Publication Date Title
ZA201407694B (en) Substituted pyrrolidine-2-carboxamides
DK2830816T3 (en) Hidtil ukendt coatingkoncept
DK3327112T3 (en) Agse-deficient stamme
SG11201404344XA (en) Substituted pyrrolidine-2-carboxamides
EP2935220A4 (en) PERI-carbinol
EP2934541A4 (en) NORIBOGAINE SUBSTITUTE
EP2920142A4 (en) MÉTHANOFULLERRÈNES
GB201203307D0 (en) Remvox
GB201205346D0 (en) Loadwatch
AU345893S (en) Treehouse
GB201217968D0 (en) Keyneck
GB201205515D0 (en) Shutterball
GB201205354D0 (en) Herbscan bookcradle
GB201205034D0 (en) Boozshooz
GB201204911D0 (en) Superswoosher
GB201204748D0 (en) Toretear
GB201204316D0 (en) Comniview
GB201204245D0 (en) MobiKey
GB201204164D0 (en) Plugstop
GB201204088D0 (en) Tidythatcable
GB201203962D0 (en) Locnlatch
GB201203776D0 (en) Sili-m8
GB201203777D0 (en) Quit-clip
GB201203808D0 (en) MicBooth
GB201203612D0 (en) Ishopfront